Sakar Healthcare Ltd
SAKAR
Company Profile
Business description
Sakar Healthcare Ltd is engaged in manufacturing Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections. The company offers its products to Sri Lanka, the Philippines, Vietnam, Cambodia, Sudan, Myanmar, Mauritius, Costa Rica, Panama, El Salvador and Paraguay.
Contact
406, Silver Oaks Comm. Complex
Opposite Arun Society
Paldi
AhmedabadGJ382 007
INDT: +91 7926584655
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
325
Stocks News & Analysis
stocks
3 global ‘buy the dip’ candidates with wide moats
Does recent share price weakness spell opportunity in these three high-quality companies? Our analysts think so.
stocks
What next for Nine Entertainment after Domain payout?
The media group has excelled in controlling what it can control. Now the focus shifts to capital deployment.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,135.20 | 24.60 | 0.27% |
| CAC 40 | 7,823.52 | 62.20 | 0.80% |
| DAX 40 | 23,703.65 | 70.70 | 0.30% |
| Dow JONES (US) | 46,108.00 | 617.08 | 1.36% |
| FTSE 100 | 9,297.58 | 72.19 | 0.78% |
| HKSE | 26,371.49 | 285.17 | 1.09% |
| NASDAQ | 22,043.07 | 157.01 | 0.72% |
| Nikkei 225 | 44,694.65 | 322.15 | 0.73% |
| NZX 50 Index | 13,237.56 | 8.41 | 0.06% |
| S&P 500 | 6,587.47 | 55.43 | 0.85% |
| S&P/ASX 200 | 8,870.00 | 27.10 | 0.31% |
| SSE Composite Index | 3,870.50 | 4.80 | -0.12% |